Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
- To assess the activity of lenalidomide in patients with previously untreated chronic
lymphocytic leukemia (CLL) age 65 and older.
Secondary Objective:
- To assess the tolerability of lenalidomide in patients with untreated CLL age 65 and
older